Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

被引：0
|
作者：
Jonsdottir, Gudbjorg
Bjorkholm, Magnus
Turesson, Ingemar
Hultcrantz, Malin
Porwit, Anna
Jethava, Yogesh
Landgren, Ola
Kristinsson, Sigurdur Y.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4396
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Upregulation of Focal Adhesion Kinase, a Potential Therapeutic Target, in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS).
    Yang, Hui
    Bueso-Ramos, Carlos E.
    Pierce, Sherry A.
    Wei, Yue
    Fang, Zhihong
    Nguyen, Martin
    Fernadez, Michael
    Cardenas-Turanzas, Marylou
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2012, 120 (21)
  • [32] Low dose Vidaza and thalidomide is an effective combination for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
    Westervelt, P.
    Amirifeli, S.
    Mehdi, M.
    Mumtaz, M.
    Alhomsi, S.
    Wang, S.
    Miron, P.
    Lata, C.
    Galili, N.
    Raza, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 354S - 354S
  • [33] Advanced care planning (ACP) intervention for older patient with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
    LoCastro, Marissa
    Sanapala, Chandrika
    Watson, Erin
    Kluger, Benzi
    Norton, Sally
    Bernacki, Rachelle
    Carroll, Thomas
    Klepin, Heidi D.
    Mendler, Jason
    Loh, Kah Poh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19004 - E19004
  • [34] CD99 IDENTIFIES DISEASE STEM CELLS IN ACUTE MYELOID LEUKEMIA (AML) AND THE MYELODYSPLASTIC SYNDROMES (MDS)
    Chung, Stephen
    Pang, Wendy
    Jan, Max
    Klimek, Virginia
    Weissman, Irving
    Majeti, Ravindra
    Park, Christopher
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S16 - S16
  • [35] MRP expression in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) and its correlation with Pgp expression.
    Poulain, S
    Wattel, E
    Cambier, N
    de Botton, S
    Cosson, A
    Fenaux, P
    Lepelley, P
    BLOOD, 1998, 92 (10) : 389A - 389A
  • [36] ABSENCE OF REARRANGEMENTS OF THE NF1 GENE IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    PREUDHOMME, C
    QUESNEL, B
    VANRUMBEKE, M
    VACHEE, A
    LAI, JL
    FENAUX, P
    BLOOD, 1993, 82 (10) : A531 - A531
  • [37] Intensive chemotherapy for patients with high risk myelodysplastic syndromes (MDS) and acute myeloid leukemia.
    Shi, J
    Shao, ZH
    Liu, H
    Chen, GB
    Song, LY
    Zhang, YZ
    Li, K
    Fu, R
    Zhao, MF
    He, GS
    Bar, J
    Chu, YL
    Yang, TY
    BLOOD, 2002, 100 (11) : 336B - 336B
  • [38] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
  • [39] Distinction of Early and Late Molecular Events In Patients with Myelodysplastic Syndromes (MDS) Who Progressed to Acute Myeloid Leukemia (AML)
    Afable, Manuel G., II
    Makishima, Hideki
    Sakaguchi, Hirotoshi
    Jerez, Andres
    Jankowska, Anna Malgorzata
    Guinta, Kathryn M.
    Abu Kar, Sara
    Traina, Fabiola
    Sugimoto, Yuka
    O'Keefe, Christine
    Tiu, Ramon V.
    Sekers, Mikkael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2011, 118 (21) : 1522 - 1523
  • [40] A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML)
    Navada, S. C.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Alvarado, Y.
    Daver, N.
    DiNardo, C.
    Konopleva, M.
    Borthakur, G.
    Azarnia, N.
    Silverman, L. R.
    LEUKEMIA RESEARCH, 2015, 39 : S45 - S45
12345